Radiology Partners vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 72)
Radiology Partners logo

Radiology Partners

LeaderHealthcare

Physician-Led Radiology Practice Management

Radiology Partners is the largest physician-led radiology practice in the US; serves 1,000+ hospital and outpatient sites in 35+ states; integrates AI-driven imaging tools; raised $700M+ in equity and debt financing;

AI VisibilityBeta
Overall Score
B72
Category Rank
#112 of 596
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
77
Perplexity
72
Gemini
70

About

Radiology Partners is the largest physician-owned and physician-led radiology practice in the United States, founded in 2012 by Rich Whitney and Scott Seidelmann and headquartered in El Segundo, California. The company partners with hospitals, health systems, outpatient imaging centers, and specialty practices to deliver comprehensive diagnostic and interventional radiology services. Unlike corporate radiology groups that are investor-owned, Radiology Partners is structured to keep radiologists in ownership and governance positions, a model the company uses to attract and retain talent in a specialty facing significant workforce shortages.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
up
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

72
Overall Score
90
#112
Category Rank
#2
79
AI Consensus
83
stable
Trend
up
77
ChatGPT
92
72
Perplexity
93
70
Gemini
89
76
Claude
96
78
Grok
95

Key Details

Category
Physician-Led Radiology Practice Management
Enterprise
Tier
Leader
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.